These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21637713)

  • 21. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.
    Shimp SK; Chafin CB; Regna NL; Hammond SE; Read MA; Caudell DL; Rylander M; Reilly CM
    Cell Mol Immunol; 2012 May; 9(3):255-66. PubMed ID: 22543833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice.
    Oishi H; Tsubaki T; Miyazaki T; Ono M; Nose M; Takahashi S
    J Immunol; 2013 Mar; 190(5):2129-37. PubMed ID: 23365086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in
    Zhou Y; Chen H; Liu L; Yu X; Sukhova GK; Yang M; Kyttaris VC; Stillman IE; Gelb B; Libby P; Tsokos GC; Shi GP
    J Immunol; 2017 Mar; 198(5):1846-1854. PubMed ID: 28093526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens.
    Lech M; Kulkarni OP; Pfeiffer S; Savarese E; Krug A; Garlanda C; Mantovani A; Anders HJ
    J Exp Med; 2008 Aug; 205(8):1879-88. PubMed ID: 18644972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.
    Lech M; Kantner C; Kulkarni OP; Ryu M; Vlasova E; Heesemann J; Anz D; Endres S; Kobayashi KS; Flavell RA; Martin J; Anders HJ
    Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice.
    Gatto M; Ghirardello A; Luisetto R; Bassi N; Fedrigo M; Valente M; Valentino S; Del Prete D; Punzi L; Doria A
    J Autoimmun; 2016 Nov; 74():208-216. PubMed ID: 27405845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.
    Koh AE; Njoroge SW; Feliu M; Cook A; Selig MK; Latchman YE; Sharpe AH; Colvin RB; Paul E
    J Autoimmun; 2011 Aug; 37(1):48-57. PubMed ID: 21561736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
    Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
    Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
    Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
    J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cells, murine chronic graft-versus-host disease and autoimmunity.
    Eisenberg RA; Via CS
    J Autoimmun; 2012 Sep; 39(3):240-7. PubMed ID: 22704961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex-related differences in autoimmune-induced lung lesions in MRL/MpJ-fas
    Elewa YHA; Ichii O; Kon Y
    Autoimmunity; 2017 Aug; 50(5):306-316. PubMed ID: 28665157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
    White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
    Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis.
    Bassi N; Del Prete D; Ghirardello A; Gatto M; Ceol M; Zen M; Bettio S; Mantovani A; Iaccarino L; Punzi L; Doria A
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):217-26. PubMed ID: 25805362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease.
    King JK; Philips RL; Eriksson AU; Kim PJ; Halder RC; Lee DJ; Singh RR
    J Immunol; 2015 Jul; 195(2):464-76. PubMed ID: 26071559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbon monoxide inhibits T cell activation in target organs during systemic lupus erythematosus.
    Mackern-Oberti JP; Obreque J; Méndez GP; Llanos C; Kalergis AM
    Clin Exp Immunol; 2015 Oct; 182(1):1-13. PubMed ID: 26095291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.
    Chesnutt MS; Finck BK; Killeen N; Connolly MK; Goodman H; Wofsy D
    Clin Immunol Immunopathol; 1998 Apr; 87(1):23-32. PubMed ID: 9576007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.